Gaelle V.
- Country
- Belgium
- Department
- cardiology
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Single-blind, investigator-initiated, randomized, controlled trial to assess the safety and efficacy of intravenous corticosteroid therapy to treat patients with acute myocarditis with mildly reduced left ventricular ejection fraction
Data & Insights
Has run more than one trial at 12 of 270 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating acute myocarditis, with particular emphasis on therapeutic interventions for patients experiencing cardiac dysfunction.
- Inflammatory Heart Conditions
- Cardiac Function Assessment
- Left Ventricular Performance
Their research focuses on evaluating steroid-based therapeutic approaches for heart inflammation management.
Therapeutic Innovation
The investigator explores advanced treatment strategies for patients with mildly reduced ejection fraction conditions, developing targeted therapeutic protocols.
- Corticosteroid Therapy
- Cardiac Recovery Protocols
- Treatment Optimization
Their work encompasses the evaluation of cardiac function improvement through innovative therapeutic interventions.
Clinical Assessments
The investigator specializes in echocardiographic evaluation of cardiac function and treatment response monitoring.
- Cardiac Imaging
- Treatment Response Monitoring
- Clinical Outcomes Assessment
Their expertise includes precise measurement of left ventricular ejection fraction and cardiac performance metrics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.